Brief Communication | Published:

Single-tube linear DNA amplification (LinDA) for robust ChIP-seq

Nature Methods volume 8, pages 565567 (2011) | Download Citation

Abstract

Genome-wide profiling of transcription factors based on massive parallel sequencing of immunoprecipitated chromatin (ChIP-seq) requires nanogram amounts of DNA. Here we describe a high-fidelity, single-tube linear DNA amplification method (LinDA) for ChIP-seq and reChIP-seq with picogram DNA amounts obtained from a few thousand cells. This amplification technology will facilitate global analyses of transcription-factor binding and chromatin with very small cell populations, such as stem or cancer-initiating cells.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Biotechniques 43, 791–797 (2007).

  2. 2.

    , & Nat. Genet. 38, 835–841 (2006).

  3. 3.

    & Nat. Protoc. 3, 1032–1045 (2008).

  4. 4.

    , , , & Biotechniques 41, 577–580 (2006).

  5. 5.

    , , , & Science 246, 810–813 (1989).

  6. 6.

    et al. BMC Genomics 7, 216 (2006).

  7. 7.

    , , , & BMC Res. Notes 1, 56 (2008).

  8. 8.

    et al. Nat. Methods 7, 47–49 (2010).

  9. 9.

    , & BMC Genomics 4, 19 (2003).

  10. 10.

    , & Nat. Methods 7, 615–618 (2010).

  11. 11.

    et al. Nucleic Acids Res. 36, e21 (2008).

  12. 12.

    , & Cold Spring Harb. Protoc. pdb.top42 (2008).

  13. 13.

    et al. Genes Dev. (in the press).

  14. 14.

    et al. Genome Biol. 9, R137 (2008).

  15. 15.

    et al. Nucleic Acids Res. 39, e35 (2011).

Download references

Acknowledgements

We thank B. Jost, S. Vicaire and S. Le Gras for Illumina sequencing and mapping to the genomes, W. van Gool for help in the data analysis, A. Krebs for help with seqMINER and D. Ceschin advice on statistics and for critical reading of the manuscript. P.S. is a postdoc at the Ligue Nationale Contre le Cancer; M.W. is supported by fellowships of the Association pour le Recherche sur le Cancer and the Fondation pour la Recherche Médicale. This work was supported by funds from the Ligue Nationale Contre le Cancer (laboratoire labelisé) and European Community contracts LSHC-CT-2005-518417 'EPITRON', LSHG-CT2005-018882 'X-TRA-NET', LSHM-CT2005-018652 'CRESCENDO' and HEALTH-F4-2009-221952 'ATLAS'.

Author information

Affiliations

  1. Department of Cancer Biology, Institute of Genetics and Molecular and Cellular Biology, Strasbourg-Illkirch, France.

    • Pattabhiraman Shankaranarayanan
    • , Marco-Antonio Mendoza-Parra
    • , Mannu Walia
    •  & Hinrich Gronemeyer
  2. Beijing Genome Institute, Guangdong, China.

    • Li Wang
    •  & Ning Li
  3. Wageningen University and Research Center–Plant Breeding, Wageningen, The Netherlands.

    • Luisa M Trindade

Authors

  1. Search for Pattabhiraman Shankaranarayanan in:

  2. Search for Marco-Antonio Mendoza-Parra in:

  3. Search for Mannu Walia in:

  4. Search for Li Wang in:

  5. Search for Ning Li in:

  6. Search for Luisa M Trindade in:

  7. Search for Hinrich Gronemeyer in:

Contributions

P.S., L.M.T. and H.G. designed and optimized LinDA. M.-A.M.-P. performed the F9-cell experiments and did the bioinformatics analysis with P.S., and M.W. did the H3396-cell experiments. N.L. and L.W. performed the Illumina HiSeq 2000 sequencing and mapping to hg19 human genome assembly. H.G. and P.S. wrote the main text of the manuscript, which M.-A.M.-P. and L.M.T. corrected and improved; P.S. and L.M.T. wrote the Online Methods section.

Competing interests

H.G., P.S. and L.M.T. filed a patent application describing the methods presented here (European patent EP11305531.3).

Corresponding author

Correspondence to Hinrich Gronemeyer.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–6 and Supplementary Tables 1–2

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nmeth.1626

Further reading